Optovin

CAS No. 348575-88-2

Optovin ( Optovin )

Catalog No. M18460 CAS No. 348575-88-2

Optovin is a TRPA1 activator, which is reversibly photoactivated.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 42 In Stock
5MG 67 In Stock
10MG 88 In Stock
25MG 178 In Stock
50MG 297 In Stock
100MG 534 In Stock
200MG 651 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Optovin
  • Note
    Research use only, not for human use.
  • Brief Description
    Optovin is a TRPA1 activator, which is reversibly photoactivated.
  • Description
    Optovin is a photoactive TRPA1 activator. Optovin activates human TRPA1 via structure-dependent photochemical reactions with redox-sensitive cysteine residues. In animals with severed spinal cords, optovin treatment enables control of motor activity in the paralyzed extremities by localized illumination. These studies identify a light-based strategy for controlling endogenous TRPA1 receptors in vivo, with potential clinical and research applications in nontransgenic animals, including humans.
  • Synonyms
    Optovin
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    TRPA1
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    348575-88-2
  • Formula Weight
    315.41
  • Molecular Formula
    C15H13N3OS2
  • Purity
    98%
  • Solubility
    DMSO : ≥ 37 mg/mL; 117.31 mM
  • SMILES
    S1C(=S)NC(=O)/C/1=C\c1c(n(c(c1)C)c1cnccc1)C
  • Chemical Name
    (Z)-5-((2,5-dimethyl-1-(pyridin-3-yl)-1H-pyrrol-3-yl)methylene)-2-thioxothiazolidin-4-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kokel D, et al. Nat Chem Biol. 2013, 9(4), 257-263.
molnova catalog
related products
  • Rimeporide

    Rimeporide (EMD87580) is a potent, selective sodium hydrogen exchanger NHE1 inhibitor.

  • AZD-3161

    AZD-3161 is a potent and selective sodium channel Nav1.7 blocker for treatment of nociceptive pain.

  • GS967

    GS967 is a novel, potent, and selective inhibitor of cardiac late sodium current(late INa).